T1	Participants 111 138	central precocious puberty.
T2	Participants 228 261	central precocious puberty (CPP).
T3	Participants 503 519	CPP in children.
T4	Participants 609 624	Twenty-two U.S.
T5	Participants 625 678	medical centers (including Puerto Rico) participated.
T6	Participants 688 807	Children diagnosed with CPP (n = 84), who were either treatment naive or previously treated with GnRHa, were recruited.
T7	Participants 808 972	Chronological age at onset of pubertal signs was less than 8 yr in girls and less than 9 yr in boys, and bone age was advanced over chronological age at least 1 yr.
